Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avotaciclib (BEY1107) in Pancreatic Cancer
NCT03579836Phase 2Recruiting
- Sponsor
- BeyondBio Inc.
- Start
- May 2018
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Avotaciclib in pancreatic ductal adenocarcinoma (PDAC), sponsored by BeyondBio Inc.. Started May 2018; status: recruiting.
02
Drugs
Avotaciclib
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03579836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03579836.